| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-030-27378-1_72 |
| P698 | PubMed publication ID | 31884651 |
| P50 | author | Ana Martínez | Q30506374 |
| P2093 | author name string | Enrique J de la Rosa | |
| Alonso Sánchez-Cruz | |||
| Catalina Hernández-Sánchez | |||
| P2860 | cites work | A molecular mechanism for the effect of lithium on development | Q24629067 |
| Angiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathy | Q33586788 | ||
| A phase II trial of tideglusib in Alzheimer's disease | Q34042842 | ||
| Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype | Q34162967 | ||
| Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study. | Q34296827 | ||
| Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa. | Q36257802 | ||
| Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium | Q36742429 | ||
| Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study | Q37154987 | ||
| Lithium prevents and ameliorates experimental autoimmune encephalomyelitis | Q37245952 | ||
| Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. | Q37389332 | ||
| The retina as a window to the brain-from eye research to CNS disorders | Q38061012 | ||
| Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments | Q38126701 | ||
| Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease. | Q38127825 | ||
| Interconnection between brain and retinal neurodegenerations | Q38211671 | ||
| Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases | Q38272835 | ||
| Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases | Q38678504 | ||
| Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). | Q39003757 | ||
| A stress survival response in retinal cells mediated through inhibition of the serine/threonine phosphatase PP2A. | Q39679478 | ||
| Inhibition of GSK3 by lithium, from single molecules to signaling networks | Q41285005 | ||
| Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease. | Q42633181 | ||
| Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy | Q42717540 | ||
| First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease | Q43907791 | ||
| Does lithium protect against dementia? | Q44119965 | ||
| Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium | Q44264546 | ||
| Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. | Q44824216 | ||
| Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
| A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. | Q50479057 | ||
| Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa. | Q54975267 | ||
| Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial | Q89025786 | ||
| Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging | Q91659272 | ||
| P304 | page(s) | 437-441 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | GSK-3 Inhibitors: From the Brain to the Retina and Back Again | |
| P478 | volume | 1185 |
Search more.